Your browser doesn't support javascript.
loading
Three new cases of bullous pemphigoid during anti-PD-1 antibody therapy.
Le Naour, S; Peuvrel, L; Saint-Jean, M; Dreno, B; Quereux, G.
Affiliation
  • Le Naour S; Department of Dermatology, Nantes University Hospital, Nantes, France.
  • Peuvrel L; Department of Dermatology, Nantes University Hospital, Nantes, France.
  • Saint-Jean M; INSERM U 1232, Nantes, France.
  • Dreno B; Immuno-Dermatology Laboratory, Nantes University Hospital, Nantes, France.
  • Quereux G; INSERM CIC 1413, Clinical Investigation Center, Nantes University Hospital, Nantes, France.
J Eur Acad Dermatol Venereol ; 32(3): e104-e106, 2018 Mar.
Article in En | MEDLINE | ID: mdl-28865162

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Pemphigoid, Bullous / Programmed Cell Death 1 Receptor / Antibodies, Monoclonal / Neoplasms Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2018 Document type: Article Affiliation country: France Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Pemphigoid, Bullous / Programmed Cell Death 1 Receptor / Antibodies, Monoclonal / Neoplasms Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2018 Document type: Article Affiliation country: France Country of publication: United kingdom